Optimise every facet of your manufacturing strategy by participating at the Cell and Gene Therapy Manufacturing Forum.
Benefits of attending:
Download this free presentation on how to design a robust and cost-effective ‘off-the-shelf’ supply chain for your cell therapy. With insights from Bone Therapeutics’ PhD Production Associate Director, Anne-Sophie LeBrun, this presentation is designed to ensure that your manufacturing process is as efficient and cost effective as possible
The Bone Therapeutics presentation will give you insights on:
Fill in your details to download this free presentation.
Back by
popular demand, the 2019 industry heatmap provides a high level overview
of the latest developments in the European novel therapy manufacturing space
across The United Kingdom, Belgium, Greece and Switzerland, among others.
With the
2018 commercialisation of prominent Autologous therapies such as KITEs Yskarta
and Novartis’ Kymriah in the global market, more and more companies are
beginning to move towards commercially based products. Yet despite these
unquestionable industry growths, challenging issues can hinder – and even halt
– groundbreaking progress in its tracks. There are still no established routes to
market and with continuous changes in regulatory requirements across
different global markets achieving any form of standardisation is
difficult.
Download this free resource to gain valuable insights on some of the biggest challenges:
Joining
this year’s curated programme will take you through a series of sessions from
translation and collaboration to ensuring GMP compliance and optimising
scalability. This year’s forum is also your one-stop shop for:
To find out more information on the sessions, download the full agenda of the conference here. To request a copy to be sent via email, please click here.
Optimise every facet of your manufacturing strategy by participating at the Cell and Gene Therapy Manufacturing Forum.
Benefits of attending:
Webinar 7-8 July
Sponsoring Cell and Gene Therapy Development Online is a unique opportunity to align your company’s offering to match the needs of key prospects, at a time when they are pivoting their process development and manufacturing strategies to drive clinical development and sustain regulatory compliance for cell and gene therapies under Covid-19 and beyond.
View the webinar prospectus by submitting the form to the right >
Who will attend?